Epstein-Barr virus in healthy individuals from Portugal;Caracterização da frequência do vírus de Epstein-Barr em dadores saudáveis de Portugal

Acta Medica Portuguesa

Volumn 24, Issue 5, 2011, Pages 707-712

  Sousa, Hugo ^a,b   Silva, João ^a   Azevedo, Luís ^a   Pinto Correia, Ana L ^a   Catarino, Raquel ^a,b   Pinto, Daniela ^a   Lopes, Carlos ^b   Medeiros, Rui ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CIRCULATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PORTUGAL; PREVENTIVE HEALTH SERVICE; VIRUS DETECTION; VIRUS GENE;

ADULT; FEMALE; HEALTH STATUS; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; PORTUGAL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84857146134     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Young LS, Muray PG: Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003;22:5108-5121
2. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768
3. Thompson MP, Kurzroc k R: Epstein-Barr virus and cancer. Clin Cancer Res 2004;10:803-821
4. Henle W, Henle G: Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies. Laryngoscope 1977;87:467-473
5. Henle W, Henle G: Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases. Ann N Y Acad Sci 1980;354:326-331
6. Henle W, Henle G: Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res 1981;41:4222-4225
7. Amon W, Farel PJ: Reactivation of Epstein-Barr virus from latency. Rev Med Virol 2004
8. Farel PJ: Tumour viruses-could they be an Achilles' heel of cancer? Eur J Cancer 2002;38:1815-1816
9. Faulkner GC, Krajews ki AS, Crawford DH: The ins and outs of EBV infection. Trends Microbiol 2000;8:185-189
10. Mogensen TH, Paludan SR: Virus-cell interactions: impact on cytokine production, immune evasion and tumor growth. Eur Cytokine Netw 2001;12:382-390
11. Thorley-Lawson DA: Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001;1:75-82
12. Kondo S, Horikawa T, Takeshita H et al: Diagnostic value of serum EBV-DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients. Cancer Sci 2004;95:508-513
13. Lin JC, Wang WY, Chen KY et al: Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461-2470
14. Tan EL, Selvaratnam G, Kananathan R, Sam CK: Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer 2006;6:227
15. Tan EL, Looi LM, Sam CK: Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma. Singapore Med J 2006;47:803-807
16. Guley ML, Fan H, Elmore SH: Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting. J Mol Diagn 2006;8: 589-597
17. Mulenbach R, Lagoda PJ, Welter C: An efficient saltchloroform extraction of DNA from blood and tissues. Trends Genet 1989;5:391
18. Cohen JI: Epstein-Barr virus infection. N Engl J Med 2000;343:481-492
19. Baumforth KR, Young LS, Flavel KJ, Constandinou C, Muray PG: The Epstein-Barr virus and its association with human cancers. Mol Pathol 1999; 52:307-322
20. Castle SC, Uyemura K, Fulop T, Makinodan T: Host resistance and immune responses in advanced age. Clin Geriatr Med 2007;23:463-479
21. Nishiwaki M, Fujimuro M, Teishikata Y et al: Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay. J Med Virol 2006;78:1635-1642
22. Rodrigues C, Pinto D, Medeiros R: Molecular epidemiology characterization of the urinary excretion of polyomavirus in healthy individuals from Portugal-a Southern European population. J Med Virol 2007;79:1194-1198